Oral Solid Dosage Contract Manufacturing Market

Table of Content

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. FMI Analysis and Recommendations

2. Market Introduction
     2.1. Market Taxonomy
     2.2. Market Definition

3. Global Oral Solid Dosage Contract Manufacturing Market Opportunity Analysis
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis

4. Global Economic Outlook
     4.1. Global Gross Domestic Product by Region & Country, 2017 – 2021

5. Market Background
     5.1. Market Trends
     5.2. Value Chain Analysis

6. North America Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028
     6.1. Introduction
     6.2. Regional Market Dynamics
            6.2.1. Drivers
            6.2.2. Restraints
            6.2.3. Trends
     6.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            6.3.1. U.S.
            6.3.2. Canada
     6.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
     6.5. Historical Market Value (US$ Mn) Analysis By Dosage Form, 2013-2017
            6.5.1. Tablets
                     6.5.1.1. Conventional/Immediate Release
                     6.5.1.2. Modified Release
                     6.5.1.3. Chewable Tablets
                     6.5.1.4. Effervescent Tablets
            6.5.2. Capsules
                     6.5.2.1. Hard Gelatin Capsules
                     6.5.2.2. Soft Gelatin Capsules/Softgels
            6.5.3. Powders & Granules
            6.5.4. Lozenges & Pastilles
            6.5.5. Gummies
     6.6. Market Size (US$ Mn) Forecast By Dosage Form, 2018–2028
     6.7. Historical Market Value (US$ Mn) Analysis By End User/Customer, 2013-2017
            6.7.1. Big Pharma or Biotechnology Companies
            6.7.2. Small & Medium Size Pharma/Biotech Companies
            6.7.3. Emerging/virtual Pharma Companies
            6.7.4. Nutraceutical Companies
     6.8. Market Size (US$ Mn) Forecast By End User/Customer, 2018–2028
     6.9. Market Attractiveness Analysis
            6.9.1. By Country
            6.9.2. By Dosage Form
            6.9.3. By End User/Customer
     6.10. Key Representative Participants Presence (Intensity Map)

7. Latin America Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028
     7.1. Introduction
     7.2. Regional Market Dynamics
            7.2.1. Drivers
            7.2.2. Restraints
            7.2.3. Trends
     7.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            7.3.1. Brazil
            7.3.2. Mexico
            7.3.3. Argentina
            7.3.4. Rest of Latin America
     7.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
     7.5. Historical Market Value (US$ Mn) Analysis By Dosage Form, 2013-2017
            7.5.1. Tablets
                     7.5.1.1. Conventional/Immediate Release
                     7.5.1.2. Modified Release
                     7.5.1.3. Chewable Tablets
                     7.5.1.4. Effervescent Tablets
            7.5.2. Capsules
                     7.5.2.1. Hard Gelatin Capsules
                     7.5.2.2. Soft Gelatin Capsules/Softgels
            7.5.3. Powders & Granules
            7.5.4. Lozenges & Pastilles
            7.5.5. Gummies
     7.6. Market Size (US$ Mn) Forecast By Dosage Form, 2018–2028
     7.7. Historical Market Value (US$ Mn) Analysis By End User/Customer, 2013-2017
            7.7.1. Big Pharma or Biotechnology Companies
            7.7.2. Small & Medium Size Pharma/Biotech Companies
            7.7.3. Emerging/virtual Pharma Companies
            7.7.4. Nutraceutical Companies
     7.8. Market Size (US$ Mn) Forecast By End User/Customer, 2018–2028
     7.9. Market Attractiveness Analysis
            7.9.1. By Country
            7.9.2. By Dosage Form
            7.9.3. By End User/Customer
     7.10. Key Representative Participants Presence (Intensity Map)

8. Western Europe Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028
     8.1. Introduction
     8.2. Regional Market Dynamics
            8.2.1. Drivers
            8.2.2. Restraints
            8.2.3. Trends
     8.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            8.3.1. Germany
            8.3.2. U.K
            8.3.3. France
            8.3.4. Italy
            8.3.5. Spain
            8.3.6. Rest of Western Europe
     8.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
     8.5. Historical Market Value (US$ Mn) Analysis By Dosage Form, 2013-2017
            8.5.1. Tablets
                     8.5.1.1. Conventional/Immediate Release
                     8.5.1.2. Modified Release
                     8.5.1.3. Chewable Tablets
                     8.5.1.4. Effervescent Tablets
            8.5.2. Capsules
                     8.5.2.1. Hard Gelatin Capsules
                     8.5.2.2. Soft Gelatin Capsules/Softgels
            8.5.3. Powders & Granules
            8.5.4. Lozenges & Pastilles
            8.5.5. Gummies
     8.6. Market Size (US$ Mn) Forecast By Dosage Form, 2018–2028
     8.7. Historical Market Value (US$ Mn) Analysis By End User/Customer, 2013-2017
            8.7.1. Big Pharma or Biotechnology Companies
            8.7.2. Small & Medium Size Pharma/Biotech Companies
            8.7.3. Emerging/virtual Pharma Companies
            8.7.4. Nutraceutical Companies
     8.8. Market Size (US$ Mn) Forecast By End User/Customer, 2018–2028
     8.9. Market Attractiveness Analysis
            8.9.1. By Country
            8.9.2. By Dosage Form
            8.9.3. By End User/Customer
     8.10. Key Representative Participants Presence (Intensity Map)

9. Eastern Europe Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028
     9.1. Introduction
     9.2. Regional Market Dynamics
            9.2.1. Drivers
            9.2.2. Restraints
            9.2.3. Trends
     9.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            9.3.1. Russia
            9.3.2. Poland
            9.3.3. Rest of Eastern Europe
     9.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
     9.5. Historical Market Value (US$ Mn) Analysis By Dosage Form, 2013-2017
            9.5.1. Tablets
                     9.5.1.1. Conventional/Immediate Release
                     9.5.1.2. Modified Release
                     9.5.1.3. Chewable Tablets
                     9.5.1.4. Effervescent Tablets
            9.5.2. Capsules
                     9.5.2.1. Hard Gelatin Capsules
                     9.5.2.2. Soft Gelatin Capsules/Softgels
            9.5.3. Powders & Granules
            9.5.4. Lozenges & Pastilles
            9.5.5. Gummies
     9.6. Market Size (US$ Mn) Forecast By Dosage Form, 2018–2028
     9.7. Historical Market Value (US$ Mn) Analysis By End User/Customer, 2013-2017
            9.7.1. Big Pharma or Biotechnology Companies
            9.7.2. Small & Medium Size Pharma/Biotech Companies
            9.7.3. Emerging/virtual Pharma Companies
            9.7.4. Nutraceutical Companies
     9.8. Market Size (US$ Mn) Forecast By End User/Customer, 2018–2028
     9.9. Market Attractiveness Analysis
            9.9.1. By Country
            9.9.2. By Dosage Form
            9.9.3. By End User/Customer
     9.10. Key Representative Participants Presence (Intensity Map)

10. Asia-Pacific Excluding Japan Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028
     10.1. Introduction
     10.2. Regional Market Dynamics
            10.2.1. Drivers
            10.2.2. Restraints
            10.2.3. Trends
     10.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            10.3.1. China
            10.3.2. India
            10.3.3. Australia and New Zealand
            10.3.4. ASEAN
            10.3.5. Rest of APEJ
     10.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
     10.5. Historical Market Value (US$ Mn) Analysis By Dosage Form, 2013-2017
            10.5.1. Tablets
                     10.5.1.1. Conventional/Immediate Release
                     10.5.1.2. Modified Release
                     10.5.1.3. Chewable Tablets
                     10.5.1.4. Effervescent Tablets
            10.5.2. Capsules
                     10.5.2.1. Hard Gelatin Capsules
                     10.5.2.2. Soft Gelatin Capsules/Softgels
            10.5.3. Powders & Granules
            10.5.4. Lozenges & Pastilles
            10.5.5. Gummies
     10.6. Market Size (US$ Mn) Forecast By Dosage Form, 2018–2028
     10.7. Historical Market Value (US$ Mn) Analysis By End User/Customer, 2013-2017
            10.7.1. Big Pharma or Biotechnology Companies
            10.7.2. Small & Medium Size Pharma/Biotech Companies
            10.7.3. Emerging/virtual Pharma Companies
            10.7.4. Nutraceutical Companies
     10.8. Market Size (US$ Mn) Forecast By End User/Customer, 2018–2028
     10.9. Market Attractiveness Analysis
            10.9.1. By Country
            10.9.2. By Dosage Form
            10.9.3. By End User/Customer
     10.10. Key Representative Participants Presence (Intensity Map)

11. Japan Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028
     11.1. Introduction
     11.2. Regional Market Dynamics
            11.2.1. Drivers
            11.2.2. Restraints
            11.2.3. Trends
     11.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
     11.4. Historical Market Value (US$ Mn) Analysis By Dosage Form, 2013-2017
            11.4.1. Tablets
                     11.4.1.1. Conventional/Immediate Release
                     11.4.1.2. Modified Release
                     11.4.1.3. Chewable Tablets
                     11.4.1.4. Effervescent Tablets
            11.4.2. Capsules
                     11.4.2.1. Hard Gelatin Capsules
                     11.4.2.2. Soft Gelatin Capsules/Softgels
            11.4.3. Powders & Granules
            11.4.4. Lozenges & Pastilles
            11.4.5. Gummies
     11.5. Market Size (US$ Mn) Forecast By Dosage Form, 2018–2028
     11.6. Historical Market Value (US$ Mn) Analysis By End User/Customer, 2013-2017
            11.6.1. Big Pharma or Biotechnology Companies
            11.6.2. Small & Medium Size Pharma/Biotech Companies
            11.6.3. Emerging/virtual Pharma Companies
            11.6.4. Nutraceutical Companies
     11.7. Market Size (US$ Mn) Forecast By End User/Customer, 2018–2028
     11.8. Market Attractiveness Analysis
            11.8.1. By Dosage Form
            11.8.2. By End User/Customer
     11.9. Key Representative Participants Presence (Intensity Map)

12. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028
     12.1. Introduction
     12.2. Regional Market Dynamics
            12.2.1. Drivers
            12.2.2. Restraints
            12.2.3. Trends
     12.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
            12.3.1. GCC Countries
            12.3.2. South Africa
            12.3.3. Rest of MEA
     12.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
     12.5. Historical Market Value (US$ Mn) Analysis By Dosage Form, 2013-2017
            12.5.1. Tablets
                     12.5.1.1. Conventional/Immediate Release
                     12.5.1.2. Modified Release
                     12.5.1.3. Chewable Tablets
                     12.5.1.4. Effervescent Tablets
            12.5.2. Capsules
                     12.5.2.1. Hard Gelatin Capsules
                     12.5.2.2. Soft Gelatin Capsules/Softgels
            12.5.3. Powders & Granules
            12.5.4. Lozenges & Pastilles
            12.5.5. Gummies
     12.6. Market Size (US$ Mn) Forecast By Dosage Form, 2018–2028
     12.7. Historical Market Value (US$ Mn) Analysis By End User/Customer, 2013-2017
            12.7.1. Big Pharma or Biotechnology Companies
            12.7.2. Small & Medium Size Pharma/Biotech Companies
            12.7.3. Emerging/virtual Pharma Companies
            12.7.4. Nutraceutical Companies
     12.8. Market Size (US$ Mn) Forecast By End User/Customer, 2018–2028
     12.9. Market Attractiveness Analysis
            12.9.1. By Country
            12.9.2. By Dosage Form
            12.9.3. By End User/Customer
     12.10. Key Representative Participants Presence (Intensity Map)

13. Forecast Factors: Relevance and Impact

14. Forecast Assumptions

15. Market Structure Analysis
     15.1. Market Structure by Tier of Companies

16. Competition Analysis
     16.1. Competition Dashboard
     16.2. Competitors Deep Dive
            16.2.1. Recipharm AB
                     16.2.1.1. Overview
                     16.2.1.2. Production Facility Description
                     16.2.1.3. Production Capacity
                     16.2.1.4. Key Developments
            16.2.2. AbbVie Contract Manufacturing
            16.2.3. Patheon N.V.
            16.2.4. Catalent Inc.
            16.2.5. NextPharma
            16.2.6. Capsugel (Lonza Group AG)
            16.2.7. Aurobindo Pharma Limited (AuroSource)
            16.2.8. Siegfried AG
            16.2.9. Piramal Pharma Solutions
            16.2.10. CordenPharma

17. Global Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028 By Region
     17.1. Introduction / Key Findings
     17.2. Historical Market Value (US$ Mn) Analysis By Region
            17.2.1. North America
            17.2.2. Western Europe
            17.2.3. Eastern Europe
            17.2.4. Latin America
            17.2.5. Asia Pacific Excluding Japan
            17.2.6. Japan
            17.2.7. Middle East and Africa
     17.3. Market Size (US$ Mn) Forecast By Region
     17.4. Market Attractiveness Analysis By Region

18. Global Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028, By Dosage Form
     18.1. Introduction/Key Finding
     18.2. Historical Market Value (US$ Mn) Analysis By Dosage Form, 2013-2017
            18.2.1. Tablets
                     18.2.1.1. Conventional/Immediate Release
                     18.2.1.2. Modified Release
                     18.2.1.3. Chewable Tablets
                     18.2.1.4. Effervescent Tablets
            18.2.2. Capsules
                     18.2.2.1. Hard Gelatin Capsules
                     18.2.2.2. Soft Gelatin Capsules/Softgels
            18.2.3. Powders & Granules
            18.2.4. Lozenges & Pastilles
            18.2.5. Gummies
     18.3. Market Size (US$ Mn) Forecast By Dosage Form, 2018–2028
     18.4. Market Attractiveness Analysis By Dosage Form

19. Global Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028, By End User
     19.1. Introduction/Key Finding
     19.2. Historical Market Value (US$ Mn) Analysis By End User/Customer, 2013-2017
            19.2.1. Big Pharma or Biotechnology Companies
            19.2.2. Small & Medium Size Pharma/Biotech Companies
            19.2.3. Emerging/virtual Pharma Companies
            19.2.4. Nutraceutical Companies
     19.3. Market Size (US$ Mn) Forecast By End User/Customer, 2018–2028
     19.4. Market Attractiveness Analysis By End User/Customer

20. Global Oral Solid Dosage Contract Manufacturing Market Analysis 2013-2017 and Forecast 2018–2028
     20.1. Market Value Share Analysis
     20.2. Y-o-Y Growth Analysis
     20.3. Absolute $ Opportunity

21. Assumptions and Acronyms Used

22. Research Methodology